Mar 3, 2010

Cellular Dynamics and Roche Conduct “Stem Cells in Drug Discovery and Development” Workshop at the Society of Toxicology Annual Meeting

Dec 16, 2009

Cellular Dynamics Announces Commercial Launch of iCell™ Cardiomyocytes for Drug Candidate Toxicity Screening

Sep 14, 2009

Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing

Aug 12, 2009

Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board

July 22, 2009

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

July 15, 2009

Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing

July 8, 2009

Cellular Dynamics International Reprograms Blood Cells into Stem Cells

July 1, 2009

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement

May 27, 2009

Cellular Dynamics Licenses Key Patent Portfolio Surrounding Cardiovascular Progenitor Cells

Dec 16, 2008

Cellular Dynamics International Appoints New Commercial, Operations and Financial Leadership

Nov 24, 2008

Cellular Dynamics International Merges Companies, Closes on $18 Million Financing

Nov 14, 2008

NIH Awards Cellular Dynamics International SBIR Grant to Develop Human Cardiomyocytes for Drug Screening

Nov 6, 2008

Cellular Dynamics International Awarded $500,000 SBIR Grant for Hematopoietic Stem Cell Research

Mar 5, 2008

Cellular Dynamics International and Roche Palo Alto Enter Agreement to Screen Drug Compounds for Cardiotoxicity